Izabela Zakrocka
@IzabelaZakrocka
Followers
765
Following
19K
Statuses
1K
Internist, nephrologist, transplantologist, Assistant Professor @Umlub_en, @Glomcon 2021-2022, ERA YNP Representative of Poland, Board Young Transplantologists
Lublin, Polska
Joined July 2014
RT @brzoskos: Dear friends, please support me and my team and vote for "Transplant Portfolio" in the Start-Up-Med Competition we joined! In…
0
3
0
RT @hjanders_hans: Now open access in @NDTsocial Disease-modifying anti-nephropathic drugs (DMANDs) - A definition from the Immunonephrol…
0
20
0
RT @hjanders_hans: Now open access at @NDTsocial HDF vs high-flux HD - a Consensus Statement from the EuDial Working Group of the @ERAkid…
0
15
0
RT @brendonneuen: Clazakizumab, an IL-6 inhibitor, improves iron metabolism & may reduce ESA use in dialysis ✅ ↓ Hepcidin (~44%) ✅ ↑ Trans…
0
17
0
RT @dra_miliflores: Felicidades a los nuevos FISN2025 Un honor tenerlos representado a nuestra región @SLANH_ @jorgericof @bernardo_moguel…
0
5
0
RT @KSusztak: 🎇Our new paper in @ScienceMagazine: Kidney Multiome-Based Genetic Scorecard Reveals Convergent Coding and Regulatory Variants…
0
37
0
RT @Tobias_B_Huber: Hamburg news: Anti-nephrin autoantibodies in steroid-resistant nephrotic syndrome @Kidney_Int. Thanks to @hengel_f…
0
21
0
RT @KSusztak: Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis | @NEJM #WCN @ISNkidneycare
0
9
0
RT @NephRodby: @MunerMohamed1 @OchsnerNephro 😉Be careful, do NOT pick a fight with @womeninnephro 😉. They are a force and you WILL lose. An…
0
5
0
RT @CKJsocial: 👍NEW 'In Context' in collaboration with @ynptweets: Genetic vs. Non-Genetic Kidney Disease: Prognosis Insights from a Multi…
0
14
0
0
0
1
RT @nephromythri: *Free Access to the 2024 Edition of “Practical Guidelines on Fluid Therapy”* 🌟 🚀 provides *FRE…
0
4
0
RT @CKJsocial: 👌NEW In Context in collaboration with @ynptweets Breaking barriers: giving HOPE to people living with HIV and end-stage re…
0
3
0
RT @brendonneuen: Rationale and design of the FAIR-HF2 trial: Ferric carboxymaltose assessment of morbidity and mortality in patients with…
0
4
0